NYSE:PRGOPerrigo Stock Price, Forecast & News

Perrigo's stock was trading at $46.04 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, PRGO stock has increased by 15.7% and is now trading at $53.28.
View which stocks have been most impacted by COVID-19.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last year. There are currently 4 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Perrigo.

Perrigo is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Perrigo.

Perrigo Company PLC (NYSE:PRGO) issued its earnings results on Wednesday, August, 5th. The company reported $1.03 earnings per share for the quarter, topping the consensus estimate of $0.87 by $0.16. The business had revenue of $1.22 billion for the quarter, compared to the consensus estimate of $1.23 billion. Perrigo had a net margin of 4.73% and a return on equity of 10.05%. The business's revenue was up 6.1% compared to the same quarter last year. During the same period last year, the business earned $0.86 EPS.
View Perrigo's earnings history.

Perrigo announced a quarterly dividend on Wednesday, July 29th. Stockholders of record on Friday, August 28th will be paid a dividend of $0.225 per share on Tuesday, September 15th. This represents a $0.90 dividend on an annualized basis and a dividend yield of 1.69%. The ex-dividend date of this dividend is Thursday, August 27th.
View Perrigo's dividend history.

Perrigo updated its FY20 earnings guidance on Wednesday, August, 5th. The company provided EPS guidance of $3.95-4.15 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.07. The company issued revenue guidance of $5.13-5.18 billion, compared to the consensus revenue estimate of $5.02 billion.

8 Wall Street analysts have issued 12-month price objectives for Perrigo's shares. Their forecasts range from $53.00 to $70.00. On average, they expect Perrigo's stock price to reach $58.43 in the next year. This suggests a possible upside of 9.7% from the stock's current price.
View analysts' price targets for Perrigo.

Press coverage about PRGO stock has been trending neutral recently, according to InfoTrie. InfoTrie rates the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Perrigo earned a media sentiment score of 0.2 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future.
View the latest news about Perrigo.

Perrigo saw a decline in short interest in the month of January. As of January 31st, there was short interest totaling 5,200,000 shares, a decline of 16.7% from the January 15th total of 6,240,000 shares. Based on an average daily volume of 1,060,000 shares, the short-interest ratio is currently 4.9 days. Currently, 3.8% of the shares of the company are sold short.
View Perrigo's Short Interest.

Some companies that are related to Perrigo include Johnson & Johnson (JNJ), Pfizer (PFE), Merck & Co., Inc. (MRK), AbbVie (ABBV), Eli Lilly And Co (LLY), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Royalty Pharma (RPRX), Horizon Therapeutics (HZNP), Mylan (MYL), Jazz Pharmaceuticals (JAZZ), Nektar Therapeutics (NKTR), Pacira Biosciences (PCRX), Corcept Therapeutics (CORT) and Zogenix (ZGNX).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Perrigo investors own include Teva Pharmaceutical Industries (TEVA), Gilead Sciences (GILD), Mylan (MYL), AbbVie (ABBV), Allergan (AGN), Netflix (NFLX), Celgene (CELG), Johnson & Johnson (JNJ), Intel (INTC) and QUALCOMM (QCOM).

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

Perrigo's stock is owned by many different institutional and retail investors. Top institutional shareholders include Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management (1.51%), Diamond Hill Capital Management Inc. (0.64%), Phoenix Holdings Ltd. (0.62%), Harel Insurance Investments & Financial Services Ltd. (0.50%), Swiss National Bank (0.39%) and Manning & Napier Group LLC (0.29%). Company insiders that own Perrigo stock include Geoffrey M Parker, Grainne Quinn, Murray S Kessler, Ronald Craig Janish, Ronald Winowiecki, Svend Andersen, Theodore R Samuels II and Todd W Kingma.
View institutional ownership trends for Perrigo.

PRGO stock was sold by a variety of institutional investors in the last quarter, including First Trust Advisors LP, Diamond Hill Capital Management Inc., Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management, Arizona State Retirement System, Andra AP fonden, Vident Investment Advisory LLC, Vident Investment Advisory LLC, and Amalgamated Bank. Company insiders that have sold Perrigo company stock in the last year include Grainne Quinn, Ronald Craig Janish, Ronald Winowiecki, and Todd W Kingma.
View insider buying and selling activity for Perrigo.

PRGO stock was acquired by a variety of institutional investors in the last quarter, including Harel Insurance Investments & Financial Services Ltd., UBS Group AG, Phoenix Holdings Ltd., Assenagon Asset Management S.A., Duality Advisers LP, Franklin Street Advisors Inc. NC, SG Americas Securities LLC, and Robeco Institutional Asset Management B.V.. Company insiders that have bought Perrigo stock in the last two years include Geoffrey M Parker, Murray S Kessler, Svend Andersen, Theodore R Samuels II, and Todd W Kingma.
View insider buying and selling activity for Perrigo.

Shares of PRGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PRGO stock can currently be purchased for approximately $53.28.

Perrigo has a market capitalization of $7.27 billion and generates $4.84 billion in revenue each year. The company earns $146.10 million in net income (profit) each year or $4.03 on an earnings per share basis. Perrigo employs 11,200 workers across the globe.

The official website for Perrigo is www.perrigo.com.

Perrigo's mailing address is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. The company can be reached via phone at 353-1709-4000 or via email at [email protected]